Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)
Close on Nov 17, 2026Market cap $740.91MP/E –Yield –
Cytek Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cytek Biosciences's price to book ratio was 2.3× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.9× to 5.4×, with a median of 2.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.3× | +0.6 |
| 2025 | Dec 31, 2025 | 1.7× | −0.5 |
| 2024 | Dec 31, 2024 | 2.2× | −0.8 |
| 2023 | Dec 29, 2023 | 3.0× | −0.3 |
| 2022 | Dec 30, 2022 | 3.3× | −2.1 |
| 2021 | Dec 31, 2021 | 5.4× | – |
See a number that looks wrong?